Novo Nordisk's pricing procedures in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of selling price gouging, declaring the stark distinction involving U.S. price ranges and those in Europe and copyright.The maker claims that good use of copyright, together with food plan and physical exercise,